Marchesini, N.; Hannun, Y. A. (2004). "Acid and neutral sphingomyelinases: roles and mechanisms of regulation". Biochem. Cell Biol. 82 (1): 27–44. doi:10.1139/o03-091. PMID15052326.
Hamaguchi, A.; et al. (2003). "A sphingosine-dependent protein kinase that specifically phosphorylates 14-3-3 (SDK1) is identified as the kinase domain of PKC: a preliminary note. Biochemical and". Biophys. Res. Comm. 307 (3): 589–594. doi:10.1016/S0006-291X(03)01070-2. PMID12893264.
Smith, E. R.; Merrill, A. H.; Obeid, L. M.; Hannun, Y. A. (2000). "Effects of Sphingosine and Other Sphingolipids on Protein Kinase C". Sphingolipid Metabolism and Cell Signaling, Part B. Methods in Enzymology. Vol. 312. pp. 361–373. doi:10.1016/S0076-6879(00)12921-0. ISBN9780121822132. PMID11070884.
Bandhuvula, P.; Saba, J. D. (2007). "Sphingosine-1-phosphate lyase in immunity and cancer: silencing the siren". Trends Mol. Med. 13 (5): 210–217. doi:10.1016/j.molmed.2007.03.005. PMID17416206.
Taha, T. A.; Argraves, K. M.; Obeid, L. M. (2004). "Sphingosine-1-phosphate receptors: receptor specificity versus functional redundancy". Biochim. Biophys. Acta. 1682 (1–3): 48–55. doi:10.1016/j.bbalip.2004.01.006. PMID15158755.
Okajima, F. (2002). "Plasma lipoproteins behave as carriers of extracellular sphingosine 1-phosphate: is this an atherogenic mediator or an anti-atherogenic mediator?". Biochim. Biophys. Acta. 1582 (1–3): 132–137. doi:10.1016/s1388-1981(02)00147-6. PMID12069820.
Peters, S. L.; Alewijnse, A. E. (2007). "Sphingosine-1-phosphate signaling in the cardiovascular system". Current Opinion in Pharmacology. 7 (2): 186–192. doi:10.1016/j.coph.2006.09.008. PMID17280869.
Marchesini, N.; Hannun, Y. A. (2004). "Acid and neutral sphingomyelinases: roles and mechanisms of regulation". Biochem. Cell Biol. 82 (1): 27–44. doi:10.1139/o03-091. PMID15052326.
Hamaguchi, A.; et al. (2003). "A sphingosine-dependent protein kinase that specifically phosphorylates 14-3-3 (SDK1) is identified as the kinase domain of PKC: a preliminary note. Biochemical and". Biophys. Res. Comm. 307 (3): 589–594. doi:10.1016/S0006-291X(03)01070-2. PMID12893264.
Smith, E. R.; Merrill, A. H.; Obeid, L. M.; Hannun, Y. A. (2000). "Effects of Sphingosine and Other Sphingolipids on Protein Kinase C". Sphingolipid Metabolism and Cell Signaling, Part B. Methods in Enzymology. Vol. 312. pp. 361–373. doi:10.1016/S0076-6879(00)12921-0. ISBN9780121822132. PMID11070884.
Bandhuvula, P.; Saba, J. D. (2007). "Sphingosine-1-phosphate lyase in immunity and cancer: silencing the siren". Trends Mol. Med. 13 (5): 210–217. doi:10.1016/j.molmed.2007.03.005. PMID17416206.
Taha, T. A.; Argraves, K. M.; Obeid, L. M. (2004). "Sphingosine-1-phosphate receptors: receptor specificity versus functional redundancy". Biochim. Biophys. Acta. 1682 (1–3): 48–55. doi:10.1016/j.bbalip.2004.01.006. PMID15158755.
Okajima, F. (2002). "Plasma lipoproteins behave as carriers of extracellular sphingosine 1-phosphate: is this an atherogenic mediator or an anti-atherogenic mediator?". Biochim. Biophys. Acta. 1582 (1–3): 132–137. doi:10.1016/s1388-1981(02)00147-6. PMID12069820.
Peters, S. L.; Alewijnse, A. E. (2007). "Sphingosine-1-phosphate signaling in the cardiovascular system". Current Opinion in Pharmacology. 7 (2): 186–192. doi:10.1016/j.coph.2006.09.008. PMID17280869.